JHL Biotech, a Taiwan developer of cheaper alternatives to patent-protected biological drugs, has raised $106 million fr...
Taipei City Government has announced that they have launched a biotechnology industry cluster as a build-operate-transfe...
Taiwan and Japan authorities have urged locals and tourists to take added precautions following an outbreak of measles. ...
OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...
JHL Biotech recently announced that the China Food and Drug Administration (CFDA) have accepted for review JHL's Clinica...
Taiwanese multinational company Acer and Taiwan's Ministry of Health and Welfare (MOHW) have jointly unveiled fluforecas...
Taiwan’s National Applied Research Labs (NAR Labs) and China Medical University Hospital (CMUH) have come together...
Hitachi Ltd. has received an order for a heavy ion therapy system from the Taipei Veterans General Hospital (Deh-Ming Ch...
The Industrial Technology Research Institute (ITRI), Taiwan, has signed a Memorandum of Understanding (MoU) with Merck, ...
Huey-jen Jenny Su, president of National Cheng Kung University (NCKU) in Tainan, and Michael Ming-chiao Lai, a former NC...
TissueGene, Inc. a leader in advanced cell and gene therapies targeting osteoarthritis (OA) announced the completion of ...
Foxconn Electronics and Uni-President Group have come together to promote personal health management by installing ...
A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U...
Medeon Biodesign, Inc., a Taiwan publicly traded medical device company, has entered into a definitive asset p...
Dutch Healthcare Authority (DHA) has approved a Clinical Trial Application for JHL Biotech's dornase alfa biosimilar, JH...
TWi Biotechnology,a clinical stage biotechnology company focused on developing inhibitors of inflammasomes. The company...
Taiwan Liposome Company, (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and...
TaiGen Biopharmaceuticals recently announced that the intravenous formulation of its new antibiotic Taigexyn (nemo...
